NO20022147D0 - Mimetiske peptider for epitope av apolipoprotein B-100, konkatamer og modifiserte peptider derav, og vaksinesammensetningsom omfatter det samme - Google Patents

Mimetiske peptider for epitope av apolipoprotein B-100, konkatamer og modifiserte peptider derav, og vaksinesammensetningsom omfatter det samme

Info

Publication number
NO20022147D0
NO20022147D0 NO20022147A NO20022147A NO20022147D0 NO 20022147 D0 NO20022147 D0 NO 20022147D0 NO 20022147 A NO20022147 A NO 20022147A NO 20022147 A NO20022147 A NO 20022147A NO 20022147 D0 NO20022147 D0 NO 20022147D0
Authority
NO
Norway
Prior art keywords
peptides
concatams
apolipoprotein
epitopes
same
Prior art date
Application number
NO20022147A
Other languages
English (en)
Other versions
NO20022147L (no
Inventor
Hyo-Joon Kim
Hae-Jung Joung
Original Assignee
Kim Hyo Joon
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from KR10-2001-0054005A external-priority patent/KR100472841B1/ko
Application filed by Kim Hyo Joon filed Critical Kim Hyo Joon
Publication of NO20022147L publication Critical patent/NO20022147L/no
Publication of NO20022147D0 publication Critical patent/NO20022147D0/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/775Apolipopeptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Child & Adolescent Psychology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO20022147A 2000-09-04 2002-05-03 Mimetiske peptider for epitope av apolipoprotein B-100, konkatamer og modifiserte peptider derav, og vaksinesammensetningsom omfatter det samme NO20022147D0 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR20000052055 2000-09-04
PCT/KR2001/001492 WO2002020040A1 (en) 2000-09-04 2001-09-04 Mimetic peptides for epitope of apolipoprotein b-100, concatemer and modified peptides thereof, and the vaccine composition comprising the same
KR10-2001-0054005A KR100472841B1 (ko) 2000-09-04 2001-09-04 아포지단백질 비-100의 에피토프에 대한 모조 펩타이드,그들의 연쇄물 또는 변형체와 이들을 함유하는 백신 조성물

Publications (2)

Publication Number Publication Date
NO20022147L NO20022147L (no) 2002-05-03
NO20022147D0 true NO20022147D0 (no) 2002-05-03

Family

ID=26638363

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20022147A NO20022147D0 (no) 2000-09-04 2002-05-03 Mimetiske peptider for epitope av apolipoprotein B-100, konkatamer og modifiserte peptider derav, og vaksinesammensetningsom omfatter det samme

Country Status (18)

Country Link
US (1) US6825318B2 (no)
EP (1) EP1315517B1 (no)
JP (1) JP2004508029A (no)
CN (1) CN1231262C (no)
AU (1) AU8628601A (no)
BG (1) BG106655A (no)
BR (1) BR0107175A (no)
CA (1) CA2389739A1 (no)
CZ (1) CZ20021571A3 (no)
EE (1) EE200200238A (no)
HU (1) HUP0203251A2 (no)
IL (1) IL149379A0 (no)
LT (1) LT4989B (no)
MX (1) MXPA02004505A (no)
NO (1) NO20022147D0 (no)
RU (1) RU2313536C2 (no)
SK (1) SK6312002A3 (no)
WO (1) WO2002020040A1 (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1636356A1 (en) * 2003-06-11 2006-03-22 Schering Aktiengesellschaft Novel modified corin molecules having substitute activation sequences and uses thereof
KR100639397B1 (ko) 2004-03-18 2006-10-26 (주)에스제이바이오메드 항비만용 면역원성 하이브리드 폴리펩타이드 및 이를포함하는 항비만 백신 조성물
US20070054298A1 (en) * 2005-08-12 2007-03-08 Kent Kirshenbaum Methods for enzyme-mediated coupling of oligomers
WO2007075335A2 (en) * 2005-12-16 2007-07-05 The Regents Of The University Of California Modulation of in utero immune programming
US8961982B2 (en) * 2005-12-16 2015-02-24 The Regents Of The University Of California Modulation of developmental immune programming and protection against cardiovascular disease, diabetes, infectious diseases, and cancer
MX2009003188A (es) * 2006-09-25 2009-05-22 Sj Biomedic Inc Polipeptidos hibridos inmunogenicos antiobesidad y composicion de vacuna antiobesidad que comprende los mismos.
CN103520713B (zh) * 2013-10-16 2015-10-28 西北农林科技大学 一种ApoB100酵母重组疫苗及其制备方法和应用
WO2017210360A1 (en) 2016-05-31 2017-12-07 Cardiovax, Llc Methods for diagnosing and treating systemic lupus erythematosus
US10858422B2 (en) 2016-05-31 2020-12-08 Abcentra, Llc Methods for treating systemic lupus erythematosus with an anti-apolipoprotein B antibody

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0975792B1 (en) * 1997-03-04 2007-10-10 Savient Pharmaceuticals, Inc. Isolation of tissue specific peptide ligands and their use for targeting pharmaceuticals to organs
AU2801299A (en) * 1998-03-04 1999-09-20 Bio-Technology General Corporation Isolation of tissue specific peptide ligands and their use for targeting pharmaceuticals to organs
JP2003525883A (ja) * 2000-03-03 2003-09-02 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム ワクチン

Also Published As

Publication number Publication date
IL149379A0 (en) 2002-11-10
CZ20021571A3 (cs) 2002-09-11
US6825318B2 (en) 2004-11-30
LT4989B (lt) 2003-01-27
BG106655A (bg) 2004-08-31
CA2389739A1 (en) 2002-03-14
EP1315517A4 (en) 2005-02-09
NO20022147L (no) 2002-05-03
RU2003109439A (ru) 2004-07-20
CN1231262C (zh) 2005-12-14
HUP0203251A2 (hu) 2003-01-28
EP1315517B1 (en) 2010-10-20
AU8628601A (en) 2002-03-22
MXPA02004505A (es) 2004-09-10
BR0107175A (pt) 2002-07-02
US20030211997A1 (en) 2003-11-13
WO2002020040A1 (en) 2002-03-14
JP2004508029A (ja) 2004-03-18
RU2313536C2 (ru) 2007-12-27
LT2002051A (en) 2002-09-25
EE200200238A (et) 2003-06-16
CN1392798A (zh) 2003-01-22
SK6312002A3 (en) 2002-09-10
EP1315517A1 (en) 2003-06-04

Similar Documents

Publication Publication Date Title
CY2019029I1 (el) Anti-tnf αντισωματα, συνθεσεις, μεθοδοi και χρησεις
DE50212615D1 (de) Lyophilisierte zubereitung enthaltend antikörper gegen den egf-rezeptor
DK1314437T3 (da) Stabiliserede antistofindeholdende præparater
DK1584685T3 (da) Tumorassocieret antigenderivater fra Mage-familien, anvendt til fremstilling af fusionsproteiner med T-hjælper epitoper og sammensætninger til vaccination
DE60235989D1 (de) Antikörper gegen opgl
ATE471344T1 (de) Antikörper gegen vla-1
DE60116439D1 (de) Gassperrfilm
ATE553775T1 (de) Impstoffzusammesetzung
EE200300264A (et) ß-amüloidpeptiidi äratundvad humaniseeritud antikehad
DK1210113T3 (da) Kombinerede vaccinepræparater
NO20023850L (no) Kompositt piezoelektrisk transformator
DE60124863D1 (de) Gegen menschliche interleukin-1-beta gerichtete rekombinante antikörper
AU5249501A (en) Synthetic peptides that bind to the hepatitis b virus core and e antigens
NO20022147L (no) Mimetiske peptider for epitope av apolipoprotein B-100, konkatamer og modifiserte peptider derav, og vaksinesammensetningsom omfatter det samme
DE60042816D1 (de) T-helferzellen-epitope
NO20014765L (no) Preparat ment for konservering av infektiöse, rekombinante adenoviruser
IS6143A (is) Peptíð úr TT veiruröð og einsérhæfð mótefni, sem bindast TT veirunni
IS6809A (is) Samsettar ónæmisglæðisblöndur
GB0115428D0 (en) Antibodies, peptides, analogs and uses thereof
WO2002090542A8 (en) Antigenic epitopes of factor viii, inhibitors directed against said epitopes and use thereof
DE60014616D1 (de) Antikörper gegen plazentaprotein 13
GB0108752D0 (en) Peptide epitopes and uses thereof
FI20000174A0 (fi) Sulkusäkki
DE10194099D2 (de) Monoklonale Antikörper gegen Humanes Cathepsin W
MXPA00008474A (es) Diseno de inmunogenos a traves del uso de fagos filamentosos recombinantes.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application